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Objective
To determine whether the rates of death and complications of
carotid endarterectomy (CE) were different in the octogenar-
ian population than in patients younger than age 80.
Summary Background Data
The utility of CE depends on the ability of the surgeon and
hospital to attain low rates of death and complications, includ-
ing all subgroups of the patient population. In the past 30
years, the number of people age 85 and older has increased
274%.
Methods
Detailed chart review was carried out on all CE procedures
done from 1979 through 1998. Descriptive demographic
data, risk factors, surgical details, length of stay, deaths, and
complications were recorded.
Results
A total of 2,398 CEs were performed in 1,970 patients; 2,180
procedures were performed in 1,783 patients younger than
80, and 218 CEs were performed in 187 patients age 80 and
older. Sixty-five percent of the octogenarians and 67% of pa-
tients younger than age 80 had neurologic symptoms. Among
asymptomatic patients, 89% had stenosis of 75% or more.
There were 62 strokes in the 2,180 procedures in the younger
group, for a stroke rate of 2.8%, and 7 strokes in the 218 pro-
cedures in the older group, for a stroke rate of 3.2%. The
death rates were 0.9% for the octogenarians and 1.4% for
the younger group.
Conclusions
Carotid endarterectomy can be safely performed in a commu-
nity hospital in patients age 80 and older. Outcomes in octo-
genarians were not significantly different than those of
younger patients and were within the range required for CE to
be considered beneficial in the prevention of stroke.
Stroke is the third leading cause of death among Amer-
icans, and its incidence is known to increase with age. One
of the major causes of stroke is carotid arterial atheromatous
disease, and prospective, randomized clinical trials have
firmly established the value of carotid endarterectomy (CE)
in the prevention of stroke from this cause.1–3 Recently
published information from the North American Symptom-
atic Carotid Endarterectomy Trial has documented contin-
ued benefit at 8 years after surgery in patients with a degree
of stenosis of 70% or greater.4 An increase in the numbers
of CE procedures performed in Scotland,5 the United States,
and Canada6 has been documented after the encouraging
r ports of the randomized controlled trials.
The utility of CE depends on the ability of the surgeon
and hospital to attain acceptably low rates of death and
complications, including all major subgroups of the patient
population. One of the above reports describing the increase
in the number of procedures expressed concern that patients
who were studied were not selectively sent to surgical
centers of high volume with documented low rates of death
and complications.6,7 We have previously reported accept-
able rates of death and complications in patients undergoing
contralateral4 and ipsilateral reoperations8 in a large com-
munity hospital/regional medical center. We also reported a
statewide study of all CE procedures performed in North
Carolina, where the observed rates of death and complica-
tions were low.9
The population of the United States is aging. In the past
30 years, the number of people age 85 and older has
increased 274%, compared with an overall population in-
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crease of 45%.10 This change is predicted to continue, and
by the year 2030 the number of people age 80 and older in
the United States will increase from approximately 8 mil-
lion to 70 million.10,11 This change in the age of the popu-
lation, combined with the increasing likelihood of stroke
with age, presents the challenge of documenting, in the
community and regional medical center, the safety of cur-
rently accepted procedures for the elderly patient.
The purpose of the current study was to determine
whether the death and complications rates of CE in our
hospital were different in the octogenarian population than
in younger patients. Our hypothesis was that there would be
no significant differences in the rates of death and compli-
cations between the two groups.
METHODS
Detailed chart review was carried out on all CE proce-
dures performed in our hospital from 1979 through 1998.
CE procedures performed in conjunction with coronary
artery bypass grafting surgery were included in the study.
Descriptive demographic data, risk factors, surgical details,
patching data, length of stay, death, and complications were
recorded. Twenty-four general, vascular, and thoracic sur-
geons and 33 surgery residents performed CE procedures
during the time period. Stroke was defined as any chart-
documented neurologic deficit that persisted until time of
discharge. Any death occurring within 30 days of surgery
was classified as a postoperative death. Strokes ending in
death were counted only as deaths, and the stroke/death rate
was calculated by adding the stroke rate and death rate.
Throughout the analysis, procedures, not patients, were
studied. Thus, a patient who had more than one CE proce-
dure was evaluated separately each time a CE procedure
was performed, not simply at the time of the first CE
procedure. Reoperations on the same side, as well as those
contralateral to a previous CE, were all included as distinct
events in the series.
Percentage figures for the degree of carotid stenosis were
preferentially taken from the radiology reports of the carotid
arteriogram, or secondarily from the ultrasound report.
Whenever a range was quoted in the radiology report, the
high-end figure was used. Three groupings of degree of
stenosis were used for comparisons: less than 50%, 50% to
75%, and greater than 75% stenosis. Notations in the chart
regarding perioperative and postoperative neurologic symp-
toms that did not allow identification as stroke, transient
ischemic attack (TIA), or cranial nerve paresis were re-
corded as unclassified events.
The association between the two age cohorts and each of
the above variables were examined using the chi-square or
Fisher exact statistic for categorical variables and the Stu-
dent t test for continuous variables.
RESULTS
A total of 2,398 CEs were performed in 1,970 patients;
2,180 procedures were performed in 1,783 patients younger
than age 80, and 218 CEs were performed in 187 patients
age 80 and older.
Demographic Profiles and Comorbid
Risk Factors
The higher proportion of men in the younger group (57%)
versus the older group (47%) was statistically significant
(Table 1). Patients age 80 and older were significantly less
likely to be smokers at the time of surgery, fewer had
undergone prior vascular surgery, and fewer had been di-
agnosed as diabetic. There were no significant differences in
the proportion taking hypertensive medications or having a
history of myocardial infarction or angina.
Indications for Surgery and Severity of
Disease
Sixty-five percent of the octogenarians and 67% of the
younger patients had neurologic symptoms. Thus, there was
no significant difference between the groups in the propor-
tion in whom neurologic symptoms were an indication for
surgery (Table 2). Among the overall group of asymptom-
atic patients, 89% of the procedures were performed for
l sions with more than 75% stenosis. Although the propor-
tion of patients with severe stenosis (.75% occlusion) was
higher in the octogenarian patients (84%) than in the
younger patients (79%), this difference was not statistically
different. Episodes of transient ischemia, including TIAs,
reversible ischemic neurologic deficit, and amaurosis fugax
















,80 2,180 67 36–79 57% 23% 22% 61% 40% 47% 24%
$80 218 83 80–90 47% 20% 24% 63% 32% 19% 17%
P .006 .25 .43 .58 .03 .001 .03
P values in bold are significant.
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were the most common neurologic indications for surgery in
both groups. Stroke and vertebrobasilar symptoms were less
common presentations. There were no significant differ-
ences between the two groups in the proportion of patients
exhibiting these presenting symptoms and signs.
Outcome Measures: Hospital Resource
and Procedure Comparison
In the older patients, surgery lasted slightly longer, more
local anesthesia was used, and fewer patients had a carotid
patch applied for closure of the arteriotomy (Table 3, Fig.
1). Patching data were available in 687 patients in the
younger group and 81 in the older group. Although there
was no significant difference between the two groups in the
proportion of patients who used the intensive care unit
(ICU) after surgery, lengths of stay (LOS) in the ICU and
the hospital were slightly longer in the older patients, but
this difference was not statistically significant. During the
study, the average LOS decreased considerably, and for the
most recent 5-year period the average LOS for patients age
80 or older was approximately 5 days (see Fig. 1). More
notably, there was no significant difference between the two
groups through each time period of the study. Currently, the
average LOS after CE in our hospital is approaching 3 days.
Outcome Measures: Death and
Complications
There were no significant differences in the two groups
with regard to unclassified perioperative and postoperative
neurologic events, nonfatal myocardial infarction, and
deaths from all causes (Table 4). One death in the octoge-
narian group was caused by cardiac arrest, the other by
cardiogenic shock; there were no deaths from cerebrovas-
cular accident (CVA) in the older group. The deaths in the
younger group were due to cardiac arrest in 6 patients,
congestive heart failure in 2, CVA in 14, pulmonary causes
in 5, and miscellaneous causes in 4. The numeric total of
percentages of strokes and deaths, although slightly higher
in the older group, was not significantly different between
the groups. The occurrence of stroke was lower in asymp-
tomatic patients than in symptomatic patients for both the
younger group (2.4% vs. 3.1%) and the octogenarians (2.7%
vs. 3.7%). This was true for deaths as well, with the greater
proportions occurring in the symptomatic patients.
An alternative method of reporting the outcome would be
to include death and complications together—that is, to
calculate the stroke rate including strokes that resulted in
death. By this method, there were 62 strokes in the 2,180
younger patients, for a stroke rate of 2.8%. There were no
Table 2. INDICATIONS FOR SURGERY AMONG SYMPTOMATIC AND ASYMPTOMATIC
PATIENTS
Age Group n














TIA, or RIND CVA
Vertobrobasilar
Symptoms
,80 2,180 0.5% 12% 88% 1% 24% 74% 69% 22% 19%
$80 218 0 3.0% 97% 3% 20% 77% 73% 24% 16%
P .01* .59* .28 .52 .35
67% of the younger group and 65% of the older group were symptomatic.
* Stenosis .75% vs. the combined groups of stenosis ,75%.
The P value in bold is significant.
CVA, cerebrovascular accident; RIND, reversible ischemic neurologic deficit; TIA, transient ischemic attack.














,80 2,180 57.2% 1.7 Mean 5 6.79 108 39% 54%
Median 5 5
$80 218 53.2% 2.0 Mean 5 7.33 100 51% 47%
Median 5 5
P .26 .41 .30 .001 .001 .21
ICU, intensive care unit; LOS, length of stay.
P values in bold are significant.
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fatal strokes in the octogenarians, so the stroke rate of 3.2%
was the same by either method in the older group.
DISCUSSION
The hypothesis of the study was confirmed: the outcome
measures for the patients age 80 and older were not signif-
icantly different from the comparison group of younger
patients. These results extend the findings of a previous
study of the outcomes of CE in the elderly.12 These results
were obtained in a large community hospital/regional med-
ical center by a group of surgeons and surgery residents who
varied considerably in age, background, formal education in
vascular fellowship programs, years of experience as a
surgeon, surgical methods, and anesthesia management.
The study was not limited to primary CE but was an
analysis of consecutive procedures, including those per-
formed concomitantly with coronary artery bypass grafting,
reoperations, and contralateral procedures. Despite these
factors, which would logically be expected to worsen out-
come measures, the stroke and death rates for both age
cohorts were within the range (,5% for symptomatic pa-
tients and,3% for asymptomatic patients) recommended
by the American Heart Association’s Ad Hoc Committee on
Carotid Surgery Standards of the Stroke Council to ensure
that the benefits of CE exceed those of nonsurgical treat-
ments.13
Restraint has been recommended by Barnett et al4 in
performing CE in patients with symptomatic stenosis less
than 70%. In this study, only 25% of the symptomatic
patients in the younger group had less than 75% stenosis,
and only 23% of the symptomatic octogenarians did. This
would suggest that surgeons involved in this study were exer-
cising restraint in their patient selection for performing CE.
Several of the surgeons whose patients were included in
the study receive patients directly, without referral from
nonsurgeons, and they have documentation in their office
records of a substantial proportion of patients who were
studied, were not recommended for surgery because the
degree of stenosis was less than 75%, and were referred to
primary care or internal medicine practitioners for medical
care. It appears that surgeons used the same indications for
CE in the octogenarian group as in younger patients.
Apart from the usual limitations of a retrospective hos-
pital chart review performed during an extended period,
other limitations of the study must be noted. The smaller
proportion of older patients who smoked at the time of CE,
who had undergone prior vascular surgery, and who were
diabetic suggests that the octogenarian cohort may represent
a selection bias that would favor a better postoperative
outcome. Did smokers die earlier, eliminating them from
further carotid disease treatment? Were the more healthy
octogenarians those who were offered surgery? Counterbal-
ancing this concern are two further considerations: the
higher proportion of women in the octogenarian group (it is
frequently noted in CE outcome studies that women have
outcomes less favorable than men) and the greater percent-
age in the older group of patients with carotid arterial
stenosis of 75% or greater. Noteworthy in this regard is the
difference in the two groups with regard to postoperative
deaths: neurologic events were the most common cause of
death in the younger group, whereas there were no deaths
from CVA in the older group.
A further limitation is the fact that the radiologic tech-
Figure 1. Length of stay for carotid endarterectomy
over time.








,80 2,180 7 (0.3%) 48 (2.2%) 31 (1.4%) 79 (3.6%)
$80 218 2 (0.9%) 7 (3.2%) 2 (0.9%) 9 (4.1%)
P .19 .34 .76 .70
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niques for measuring the degree of carotid stenosis were not
uniform during the study period. They have changed over
time and are currently those outlined and used in the North
American Symptomatic Carotid Endarterectomy Trial.1 An
additional caution relates to the methodology for the anal-
ysis of the data. Because this study examined procedures
rather than patients, and a patient may have undergone
multiple procedures, the assumption of statistical indepen-
dence cannot be made. Because statistical independence
cannot be assumed, multiple logistic regression analyses of
outcomes may not be done.
Do patients age 80 and older live long enough to expe-
rience the benefit of CE in the prevention of stroke? Infor-
mation from the National Center for Health Statistics indi-
cates that the average number of years of life remaining at
age 80 is 7.2 years for a white man and 9.1 years for a white
woman. The average number of years of life remaining at
age 85 is 5.3 years for a white man and 6.5 years for a white
woman. Predictions are not available for those age 90 and
95.12,13
In the Asymptomatic Carotid Atherosclerosis Study,3 the
relative risk reduction of stroke and death was less for
women than for men, but this consideration is clouded by
the small number of women in the trial. Most outcome
studies of CE have found a higher rate of death and com-
plications among women. These concerns regarding the
possible limitations of the value of CE in women must be
balanced against the longer anticipated life span in women
in which the benefit of surgery could be expressed.
Patching of the arteriotomy closure did not become part
of the carotid surgical procedure in our institution until 1994
and was not commonly done until 1997 and 1998. Patching
has been increasingly favored, and in 1998, a patch closure
was used in 62% of all CE procedures. Data regarding this
variable must be interpreted with this caution in mind.
From 1995 on, we noted an significant increase in the
number of CEs performed each year and a marked change in
the ratio of symptomatic to asymptomatic patients. In 1993,
80% of the patients who underwent CE were symptomatic,
but by 1998 this percentage had decreased to 55%.
The outcome measures noted in this study compare fa-
vorably with those of other published studies for the elderly
undergoing CE. This report has the largest published group
of CE procedures in patients age 80 and older. The reported
range for stroke has been 0% to 6%; that for death has been
0.9% to 2.2% (Table 5).14–18 However, an appropriate ca-
veat is that the results reported in this study may not be
directly applicable to all community hospitals. Several ele-
ments were in place that have contributed to our positive
outcomes, including outstanding imaging skill and technol-
ogy, a computer-based carotid surgery registry where out-
comes were regularly monitored, the existence of regularly
held morbidity and mortality conferences where complica-
tions and deaths were discussed, and surgeons who were all
American Board of Surgery eligible or certified.
Proof of benefit of CE in the prevention of stroke in this
lder age group was beyond the scope of this study of
outcomes. Such a conclusion would require a comparison of
stroke and death incidence with similar-aged patients who
were followed up without surgery. Because this study was
retrospective, we could not, and did not intend to, analyze
patients who had indications for but did not undergo surgery.
It is estimated that in 1999 approximately 50% of the
patients cared for by a general surgeon in community prac-
tice are age 65 or older.19 The aging of the population will
continue, and in a short time, general surgeons may increas-
ingly become gerontologists who perform surgery. Thus,
the outcomes of surgical procedures found valuable in
younger patients warrant validation in the elderly, where the
number and severity of concomitant medical conditions
threaten the outcomes of surgical treatment.20,21
CONCLUSIONS
Carotid endarterectomy can be safely performed in a
community hospital in patients age 80 and older with out-
comes that are not significantly different than those of
younger patients and that are within the range required in
younger patients for CE to be considered beneficial in the
prevention of stroke.
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Discussion
DR. IRVING L. KRON (Charlottesville, Virginia): I want to thank
Dr. Maxwell for not only providing me the manuscript well in
advance—usually what’s meant by “well in advance” is about 12
minutes before the paper—but an extremely well-written paper at
that.
A careful analysis of this is absolutely critical for good results.
If you don’t really know what you are doing other than the day
before, you just can’t evaluate and improve things. And I believe
Dr. Maxwell’s point is well founded and that you can do these
patients over 80 with excellent results.
I have two questions for Dr. Maxwell: is there any age beyond
which one should not do a carotid endarterectomy in an asymp-
tomatic patient? I think he has demonstrated that you can do
asymptomatic patients at 80, but is there any older age?
The second, which he did not address but I am sure he has the
data for, is, does the experience of the surgeon improve results? As
you well know, this has been demonstrated in coronary bypass
surgery and certain other papers on carotid endarterectomy.
DR. JAMES M. SEEGER (Gainesville, Florida): I’d also like to
thank Dr. Maxwell for providing me the paper in a very timely
fashion. I think I got his paper before we got ours done.
Dr. Maxwell and his colleagues are certainly to be congratulated
on these excellent results, and Dr. Maxwell is to be congratulated
for his nice presentation. From a retrospective review of 2,000
carotid endarterectomies done over 20 years, they found no dif-
ference in thepostoperative mortality, stroke rate, and incidence of
nonfatal myocardial infarction between patients under the age of 80
and those 80 and older. This suggests to them that the risk of carotid
endarterectomy in appropriately selected patients age 80 and older is
no different from the risk of this procedure in younger patients.
Being retrospective, this review has certain problems, one of
which is that it is difficult to determine what the selection criteria
for carotid endarterectomy in patients age 80 and older were. They
appear to be different in that those patients were more commonly
female, and less likely to be smokers and to have diabetes, com-
pared to the younger patients. Without being able to understand the
precise criteria by which Dr. Maxwell and his colleagues selected
the 187 patients undergoing carotid endarterectomy over the age of
80, it is difficult to apply this information to our own practice. This
generates my first question. Can you elaborate on the selection
criteria? Were all patients 80 or older in your institution who had
symptoms referred for carotid endarterectomy, or were some
treated medically? Similarly, were only the best-risk patients with
asymptomatic carotid disease, as I suspect, referred for this pro-
cedure?
Even understanding the selection process, there remains a ques-
tion in my mind—not whether carotid endarterectomy can be done
safely in elderly patients but whether the procedure will be of
value in such patients, particularly those with asymptomatic dis-
ease. Neither the North American Symptomatic Carotid Endarter-
ectomy trial nor the Asymptomatic Carotid Atherosclerosis trial
included patients in this age range, so we do not have prospective
randomized data suggesting benefit in this age group. Cronnen-
wett, using a decision analysis model, demonstrated the cost ef-
fectiveness and therefore the benefit of carotid endarterectomy to
have a break point between 72 and 79 years, given the data from
the randomized trials. This generates my second question. What
evidence do you have that the extension of carotid endarterectomy
to patients 80 and older in your community was of benefit? You
appropriately suggest in your manuscript that elderly patients have
a higher risk of stroke and that this population is growing. Do you
know the incidence of stroke in patients 80 and older in your
community and is that incidence lower than predicted?
Because a reduction of stroke risk is seen between 18 and 24
months after carotid endarterectomy in patients with symptomatic
disease, the procedure may be of benefit in older patients with
symptomatic carotid disease. In contrast, I am significantly more
uncertain about the benefit in the asymptomatic patients. The
stroke risk reduction in the Asymptomatic Carotid Endarterectomy
Study was only 1% per year, was not seen until 5 years after the
procedure, and was not present in women. As more than half of the
patients age 80 or older undergoing carotid endarterectomy in your
study were women and 35% were asymptomatic, do you believe
these individuals actually benefitted from this procedure?
Finally, Dr. Thomas Huber from our institution showed that in
the state of Florida, after the release of the Asymptomatic Carotid
Endarterectomy Study results, there was a 68% increase in the
number of carotid endarterectomies being done, and the largest
percentage increase occurred in the patients over the age of 85. Did
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you see similar results in elderly patients with asymptomatic
disease who had an increase in the number of carotid endarterec-
tomies being done in the more recent time period?
By presenting his data, Dr. Maxwell has raised an important
question of whether carotid endarterectomy should be used in
elderly patients. He has taken the first step toward answering this
question by demonstrating that in a selected group of elderly
patients, carotid endarterectomy can be done safely. However, at
least for me, the benefit of the procedure in elderly patients
remains uncertain, particularly in patients with asymptomatic dis-
ease. Clearly, further work needs to be done, but this study is a
good beginning. Thank you.
DR. THOMAS F. DODSON (Atlanta, Georgia): I’d be remiss if I
didn’t comment that in August 1953, Dr. DeBakey, a member of
this Association, did the first carotid endarterectomy—among his
many firsts, that was one of the seminal firsts in his career.
This paper presented by Dr. Maxwell and colleagues suggests
that patients over the age of 80 have no greater morbidity and
mortality than those under the age of 80. This is an extremely
important issue, partly because in 2030, I will be 85, and I may be
coming under the knife if I live that long. It is also important
because stroke continues to be a major source of morbidity and
mortality in this country, with nearly 500,000 cases, and approx-
imately a third of those individuals dying as a result.
Thankfully, we now have a large amount of data on which to
base our decisions for or against operation. This data comes from
the result of several randomized prospective trials done on both
asymptomatic and symptomatic patients in the early part of this
decade. However, I would caution you, unless you think the issue
has been totally settled, if you read theN w York Timesabout 2
weeks ago, you will see there is an advertisement from a prominent
New York hospital which suggests that stents are the way to go in
carotid surgery and that conventional surgery is—and I quote—“a
thing of the past.”
I would summarize the data from the randomized prospective
trials in this manner: in symptomatic patients, those with less than
50% narrowing are better treated by medical means. Those with
50% to 69% narrowing show only a moderate benefit by operation
and continue to remain in what I would call a gray zone, depending
upon risk-benefit issues. Those with greater than 70% stenosis,
again in symptomatic patients, are better treated by operation.
Patients who are asymptomatic are somewhat more difficult to
discuss. This is because if they have 60% stenosis or greater, it
appears that they are better treated by operation, but you have to
keep your combined morbidity and mortality less than or equal to
3%. So I have three questions based on the information we have
been given:
What studies did you perform to suggest the need for carotid
endarterectomy? Did you do ultrasound, arteriograms, MR angios?
What exactly did you do to look at these patients? That’s important
because if you do arteriograms, your stroke rate is about 1%, and
that adds to your ultimate stroke and potential death rate.
Secondly, in symptomatic patients, what degree of narrowing
did you accept as an indication for operation? The study by Barnett
in theNew England Journalin 1998 concluded that many patients
with less than 70% stenosis will not be considered candidates for
operation when the risks and benefits are carefully weighed. I
noted in your paper that 68% of the patients greater than age 80 were
symptomatic and 72% younger than 80 were symptomatic as well.
My final question relates to your stroke and death rate in the
asymptomatic patients. Your overall stroke and death rates were
3.6% in patients less than 80 and 4.1% in patients greater than 80.
But, as noted earlier, the benefits of carotid endarterectomy mark-
edly diminish beyond a stroke and death rate of 3% in asymptom-
atic patients. What was your stroke and death rate inasymptomatic
patients?
DR. J. GARY MAXWELL (Closing Discussion): Dr. Dodson, can I
respond first with a definition of “elderly”? It’s 15 years older than
whatever I am.
Let me start with Dr. Kron’s questions. Is there any age beyond
which an asymptomatic patient should be operated upon? The
average number of years of life remaining for a white man age 80
in the United States in 1999 is 7.2 years; for a white woman age
80, the anticipated lifespan is 9.1 years. At age 85, a white man has
an anticipated lifespan of 5.3 years, and an 85-year-old woman, an
anticipated lifespan of 6.5 years.
The National Center for Health Statistics does not give numbers
for age 90 and 95, but these figures illustrate the answer given
when I posed this question to several of our community surgeons.
Their answer is that age alone is an insufficient consideration, but
the decision is based on a balance of considerations of the antic-
ipated lifespan of that patient, and his or her comorbid conditions
and overall vitality. They do not consider age in isolation from
other considerations. We have two patients age 96 in this database
who have had uncomplicated carotid operations.
The second question, Dr. Kron, does the frequency of doing the
operation improve the results? I have researched our data and I
have made a graph. I entered the combined stroke and death rate
on the X axis, and the total number of carotid endarterectomies
done by each active surgeon in our hospital. The best records were
the surgeons with the lowest volumes. They had 0% stroke and
death rate. The worst surgeon had a rate of 5% at about 125 cases.
Thus, it appears that volume influences the outcome only at the
extremes of the curve, being lowest when the surgeon has done
less than 100 cases or more than 250 with little difference in the
majority of surgeons in the middle volumes of 100 to 250. Dr.
Kron, I know that’s not what you were hoping to show, but that is
the data as we have it.
Dr. Seeger had several questions. Were all patients with symp-
toms referred for carotid endarterectomy? I do not have the data to
support my answer, but would respond that many patients are
retained by the neurologist or the internist and treated medically,
without the opinion or the knowledge of the surgeon. Conversely,
several surgeons have their own diagnostic vascular units, and
some proportion of the patients present directly to the surgeon
without an intervention by a primary care physician or neurologist
or internist. The surgeons tell me that they do a very fair job among
an increasingly educated population about the risks and benefits of
carotid endarterectomy, and that on the basis of the diagnostic
studies they perform, they turn down a number of patients who
present directly. Unfortunately, I can’t provide the comparison
data that we’d like to have to compare the medically and surgically
treated groups.
Dr. Seeger’s second question: do we have evidence that carotid
endarterectomy in patients in our community was of benefit and
what is the incidence of stroke in those age 80 and older in our
community? To properly answer this question, we would need to
have followed this patient group and documented that their evi-
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dence of stroke was less than that of a controlled population treated
medically and not operated on. Unfortunately, I don’t have this
data, nor do I have the data that would tell me what the stroke
incidence is in any particular age group in our community.
What about the benefit in women who are asymptomatic? Dr.
Seeger alludes to several considerations. In the ACES trial, the
relative risk of reduction for stroke and death was far less for
women than for men, but this was clouded by the small numbers
of women in that trial. A second consideration is that most out-
come studies of carotid endarterectomy find a higher rate of stroke
and death in women. Certainly, I would agree with both of these
concerns, but I would like to point out the longer survival period
for women, and that the stroke risk for women should be consid-
ered even at age 85 and beyond, in view of their prolonged
survival.
Dr. Seeger’s final question, does the proportion of patients who
are asymptomatic account for the increased numbers of carotid
endarterectomies done? The simple answer is yes. We have noted
a dramatic increase, beginning about 1994–95, in the number of
carotid endarterectomies done. In 1993, 80% of all patients under-
going carotid endarterectomy in our institution were symptomatic.
In 1998, this has decreased; only 55% are symptomatic.
Dr. Dodson asked what diagnostic studies were done. During a
great majority of the study period we have presented, the diagnos-
tic studies were ultrasound followed by arteriogram. In 1999, a
rather dramatic change has occurred and now the predominant
method of evaluation is a duplex study followed by an MRA, with
arteriograms reserved only for problem patients where the question
of complete occlusion or where the distinction between certain
grades of stenosis need to be made with more precision.
Of patients who were symptomatic, what percent of stenosis was
accepted? We selected 75% because we felt this would get away
from the concern with the debate over 60% and 70% and the
uncertainties of the measurement of the diagnosis by our radiolo-
gist, as this methodology has changed over time. We selected a
higher percentage of 75% in the symptomatic patients and pre-
sented the results to you on the basis of that number.
Dr. Dodson asked about the stroke and death rate in asymptom-
atic patients. For patients less than age 80, the stroke rate was 2.4%
and the death rate was 0.7%. For patients 80 and older who were
asymptomatic, the stroke rate was 2.7% and the death rate zero.
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